Source:http://linkedlifedata.com/resource/pubmed/id/11395033
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2001-6-7
|
pubmed:abstractText |
In order to investigate the metabolism of apo A-IV within TRL and plasma, we assessed TRL and plasma apo A-IV kinetics in 19 and 4 subjects, respectively, consuming an average US diet for a 6-week period. At the end of this diet study, each subject received a primed-constant infusion of deuterated leucine over a 15 h time period with hourly feeding, and blood samples were drawn at 10 time points. TRL was separated by ultracentrifugation. Apo A-IV was isolated by immunoprecipitation and/or SDS-PAGE. Apo A-IV concentrations were determined by immunoelectrophoresis. Stable isotope tracer/tracee ratios were measured by gas chromatography/mass spectrometry, and the data were analyzed by multicompartmental modeling. The mean concentrations of plasma and TRL apo A-IV during the isotope infusion period were 21.0+/-3.2 and 0.66+/-0.25 mg/dl, respectively, and these values were 11.5 and 30.5% higher than those of fasting samples. The mean TRL and plasma apo A-IV residence times (RT) were 1.97+/-0.57 and 2.71+/-0.65 days, and transport rates (TR) were 0.17+/-0.19 and 3.90+/-1.24 mg/kg per day, respectively. There were significant correlations between TRL apo A-IV concentrations and TR (r(2)=0.79, P<0.001), and between TRL apo A-IV pool size and TRL cholesterol levels (r(2)=0.29, P=0.02). Our data indicated that; (1) TRL apo A-IV has a RT of 1.97 days which is similar to that earlier reported for HDL apo A-IV; (2) Apo A-IV recirculates between TRL and other slowly turning over pools; (3) the primary determinant of TRL apo A-IV levels is its TR; and (4) there is no correlation between TRL apo A-IV and apo B48 fractional catabolism in TRL.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0021-9150
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
156
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
363-72
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11395033-Adult,
pubmed-meshheading:11395033-Aged,
pubmed-meshheading:11395033-Apolipoproteins A,
pubmed-meshheading:11395033-Coronary Artery Disease,
pubmed-meshheading:11395033-Female,
pubmed-meshheading:11395033-Humans,
pubmed-meshheading:11395033-Lipoproteins,
pubmed-meshheading:11395033-Male,
pubmed-meshheading:11395033-Middle Aged,
pubmed-meshheading:11395033-Radioimmunoassay,
pubmed-meshheading:11395033-Reference Values,
pubmed-meshheading:11395033-Risk Assessment,
pubmed-meshheading:11395033-Sensitivity and Specificity,
pubmed-meshheading:11395033-Triglycerides
|
pubmed:year |
2001
|
pubmed:articleTitle |
Human apolipoprotein A-IV metabolism within triglyceride-rich lipoproteins and plasma.
|
pubmed:affiliation |
Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington Street 02111, Boston, MA, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|